Oncolytic adenovirus Ad5/3-delta24 and chemotherapy for treatment of orthotopic ovarian cancer.
about
SPECT/CT imaging of hNIS-expression after intravenous delivery of an oncolytic adenovirus and 131IAnti-tumor function of double-promoter regulated adenovirus carrying SEA gene, in the treatment of bladder cancer.Conditionally replicating adenovirus expressing TIMP2 increases survival in a mouse model of disseminated ovarian cancerCombination of a MDR1-targeted replicative adenovirus and chemotherapy for the therapy of pretreated ovarian cancer.Oncolytic immunotherapy: where are we clinically?Oncolytic adenovirus and doxorubicin-based chemotherapy results in synergistic antitumor activity against soft-tissue sarcoma.A new generation of serotype chimeric infectivity-enhanced conditionally replicative adenovirals: the safety profile of ad5/3-Δ24 in advance of a phase I clinical trial in ovarian cancer patients.Oncolytic virotherapy for ovarian cancer.Downregulation of Mcl-1 synergizes the apoptotic response to combined treatment with cisplatin and a novel fiber chimeric oncolytic adenovirusA phase I clinical trial of Ad5/3-Δ24, a novel serotype-chimeric, infectivity-enhanced, conditionally-replicative adenovirus (CRAd), in patients with recurrent ovarian cancerOncolytic adenoviral gene therapy in ovarian cancer: why we are not wasting our time.Combining conditionally replicating adenovirus-mediated gene therapy with chemotherapy: a novel antitumor approach.Tropism-modification strategies for targeted gene delivery using adenoviral vectors.Synergistic anti-tumor efficacy of immunogenic adenovirus ONCOS-102 (Ad5/3-D24-GM-CSF) and standard of care chemotherapy in preclinical mesothelioma model.The oncolytic adenovirus AdΔΔ enhances selective cancer cell killing in combination with DNA-damaging drugs in pancreatic cancer models.An oncolytic adenovirus defective in pRb-binding (dl922-947) can efficiently eliminate pancreatic cancer cells and tumors in vivo in combination with 5-FU or gemcitabine.Improved potency and selectivity of an oncolytic E1ACR2 and E1B19K deleted adenoviral mutant in prostate and pancreatic cancers.The E1B19K-deleted oncolytic adenovirus mutant AdΔ19K sensitizes pancreatic cancer cells to drug-induced DNA-damage by down-regulating Claspin and Mre11HER3 targeting of adenovirus by fiber modification increases infection of breast cancer cells in vitro, but not following intratumoral injection in mice.Role of cell surface molecules and autologous ascitic fluid in determining efficiency of adenoviral transduction of ovarian cancer cells.Sensitisation to mitoxantrone-induced apoptosis by the oncolytic adenovirus Ad∆∆ through Bcl-2-dependent attenuation of autophagy.
P2860
Q27307734-A3EED192-AED4-4366-9B3C-BBE98F969D66Q34048741-F5903E06-2E8A-4894-99F9-774CD8BC683CQ34055529-40F44121-CC0B-4EC1-8050-1C9B26BFC51AQ34115068-F9A61A8C-04D8-4AB9-8698-7F7CB28F10F8Q34405325-88878218-0B46-438A-8B8B-5719D5DC3416Q34426949-38639191-8991-4D81-839A-D824C8EC6314Q35101968-2CB00040-777D-49D3-AE93-33A246CE4DF0Q35597082-AB1542BD-AD29-4561-8DC3-2D44E0E3BB35Q36642630-750E8349-E57A-43BE-B110-16C7548D3E5AQ37107332-3308D664-5598-4610-94A3-92DFD271FC04Q37448942-4C8E94D3-23DD-4043-8775-46844A50E85FQ37867584-0BFEAB36-90E9-4A57-9C6A-1EB0D909B73DQ38614156-7ED4B21E-EB40-49D4-AED2-9C08243B478FQ38765125-6F8B6CE0-39A8-4A65-980F-2E99F249B187Q39462851-78B2C297-52AA-40D6-B060-19630D6C69C7Q39491356-EF57243B-71E4-48EC-BF6A-FAA794E505BCQ39752863-FFFF4125-D050-41E6-98A5-AD5EF1FB4167Q40913003-D8500FB2-D24E-4026-805C-DD81AC33E563Q42288961-DDB2E177-8620-478D-965E-DAE451C99B65Q43030471-C6AECEA5-91F2-4BD6-B02A-DBF5E0A19611Q47549552-0A86E62C-6CB4-4376-864A-0F128A678E49
P2860
Oncolytic adenovirus Ad5/3-delta24 and chemotherapy for treatment of orthotopic ovarian cancer.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Oncolytic adenovirus Ad5/3-del ...... of orthotopic ovarian cancer.
@en
type
label
Oncolytic adenovirus Ad5/3-del ...... of orthotopic ovarian cancer.
@en
prefLabel
Oncolytic adenovirus Ad5/3-del ...... of orthotopic ovarian cancer.
@en
P2093
P921
P1433
P1476
Oncolytic adenovirus Ad5/3-del ...... of orthotopic ovarian cancer.
@en
P2093
Dung-Tsa Chen
Merja Särkioja
Ralf Bützow
Renee A Desmond
P304
P356
10.1016/J.YGYNO.2007.09.013
P407
P577
2007-10-22T00:00:00Z